Emerging Options for the Management of Non-Small Cell Lung Cancer

Emerging Options for the Management of Non-Small Cell Lung Cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Daniel Binder, Karin Hegenbarth
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-08-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://www.la-press.com/emerging-options-for-the-management-of-non-small-cell-lung-cancer-article-a3843

Similar Items

Emerging Options for the Management of Non-Small Cell Lung Cancer
by: Daniel Binder, et al.
Published: (2013-01-01)

Emerging treatment options in the management of non-small cell lung cancer
by: Filosso PL, et al.
Published: (2011-06-01)

New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer
by: Weise AM, et al.
Published: (2014-08-01)

Anaplastic lymphoma kinase-positive metastatic non-small-cell lung cancer: Emerging resistance and treatment options
by: Amba Prasad Dubey, et al.
Published: (2020-01-01)

Emerging therapies for non-small cell lung cancer
by: Chao Zhang, et al.
Published: (2019-04-01)

Therapeutic options in older patients with metastatic non-small cell lung cancer
by: Elisabeth Quoix
Published: (2012-09-01)

Adjuvant chemotherapy options for early stage non-small cell lung cancer
by: Manali ePatel, et al.
Published: (2011-11-01)

Emerging therapeutic agents for advanced non-small cell lung cancer
by: Ruqin Chen, et al.
Published: (2020-05-01)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
by: William Boland, et al.
Published: (2010-11-01)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
by: Sara Elena Rebuzzi, et al.
Published: (2021-03-01)

Surgical management of non-small-cell lung cancer
by: Bamousa Ahmed, et al.
Published: (2008-10-01)

Emerging therapies for small cell lung cancer
by: Sen Yang, et al.
Published: (2019-05-01)

The Emerging Importance of Tumor Genomics in Operable Non-Small Cell Lung Cancer
by: Harry B. Lengel, et al.
Published: (2021-07-01)

The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
by: Valerio Gristina, et al.
Published: (2020-12-01)

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
by: M Tiseo, et al.
Published: (2010-05-01)

Emerging roles of Nrf2 signal in non-small cell lung cancer
by: Yijun Tian, et al.
Published: (2016-02-01)

Relapsed small cell lung cancer: treatment options and latest developments
by: Nobuhiro Asai, et al.
Published: (2014-03-01)

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
by: Arik Bernard Schulze, et al.
Published: (2019-05-01)

Current and future treatment options for exon 14 skipping alterations in non-small cell lung cancer
by: Lingzhi Hong, et al.
Published: (2021-02-01)

First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?
by: Ajaz Bulbul, et al.
Published: (2018-04-01)

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib
by: Rothschild SI
Published: (2016-05-01)

Current management of rearranged non-small cell lung cancer
by: Thomas E Stinchcombe
Published: (2020-07-01)

Management of Non-Small Cell Lung Cancer: The Era of Immunotherapy
by: Tiziana Vavalà
Published: (2018-06-01)

THE MANAGEMENT OF BRAIN METASTASES IN NON-SMALL CELL LUNG CANCER
by: Scott eOwen, et al.
Published: (2014-09-01)

Evolution in the management of non-small cell lung cancer in Brazil
by: Caio Júlio Cesar dos Santos Fernandes

Management of patients with non small cell lung cancer in Sweden
by: Rendel, Filip
Published: (2008)

Management of patients with advanced non-small cell lung cancer: role of gefitinib
by: Vamsidhar Velcheti, et al.
Published: (2010-04-01)

Hypoxic markers in non-small cell lung cancer
by: Swinson, Daniel
Published: (2004)

Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives
by: Feld E, et al.
Published: (2017-07-01)

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
by: Gregory D. Jones, et al.
Published: (2021-04-01)

The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
by: Yi-Chen Zhang, et al.
Published: (2017-10-01)

KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
by: Mingying Xie, et al.
Published: (2021-05-01)

Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib
by: El-Osta H, et al.
Published: (2015-09-01)

Risk factors and management of oligometastatic non-small cell lung cancer
by: Akshar N. Patel, et al.
Published: (2016-08-01)

Review of checkpoint immunotherapy for the management of non-small cell lung cancer
by: Raju S, et al.
Published: (2018-07-01)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
by: Paul E. Van Schil, et al.
Published: (2017-10-01)

Post‐diagnosis weight loss as a prognostic factor in non‐small cell lung cancer
by: Daniel S. Mytelka, et al.
Published: (2018-02-01)

Angiogenesis Related Markers In Non-Small Cell Lung Cancer
by: Brattström, Daniel
Published: (2003)

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer
by: Ana Turkaj, et al.
Published: (2018-07-01)

Gefitinib in Non Small Cell Lung Cancer
by: Raffaele Costanzo, et al.
Published: (2011-01-01)